Role of erythropoietin and its receptor in the development of endometriosis in rats

Journal Title: UNKNOWN - Year 2019, Vol 20, Issue 1

Abstract

Objective: Besides its hematopoietic function, erythropoietin (EPO) may protect tissues from degenerative disorders. As such, EPO and its receptors were revealed in nonhematopoietic cells, including stromal and endometrial epithelial cells. However, the role of EPO in endometrial disorders is still unknown. Here, we aimed to examine the role of EPO and its receptor activation in the development of endometriosis in rats. Material and Methods: Animals were treated with EPO, darbepoietin (the synthetic form of EPO) or EPO’s receptor activator, methoxy polyethylene glycol-epoetin beta (MIRCERA), after development of endometriosis. Endometriosis was induced by estrogen-administration following surgical attachment of endometrial surface on the inner abdominal wall. Treatments were started 3 weeks after induction of endometriosis and continued for the following 3 weeks. For the analysis of recurrence of endometriosis, additional analyses were conducted 3 weeks after cessation of treatments. Results: As compared with vehicle-treated animals, lesion size was reduced significantly and recurrence of endometriosis was not observed in all treatment groups. Histopathologic examination revealed that EPO and darbepoietin were more effective than MIRCERA- and vehicle-treated animals. Conclusion: Here we provide evidence that EPO is a promising candidate for the treatment of endometriosis. Our histopathologic results in particular indicate that EPO is more effective than its receptor activator MIRCERA in the development endometriosis.

Authors and Affiliations

Mehmet Yalçın Günal, Mehmet Ozansoy, Ülkan Kılıç, İlknur Keskin, Ekrem Musa Özdemir, İsmail Aslan, Zehra Eren, Cenk Ersavaş, Ertuğrul Kılıç

Keywords

Related Articles

The effect of progesterone use in the first trimester on fetal nuchal translucency

Objective: To evaluate the possible association between progesterone use in the first trimester of pregnancy and fetal nuchal translucency (NT). Material and Methods: This is an observational case-control study, which wa...

Pregnancy in papillary thyroid cancer survivors

Objective: To evaluate “papillary thyroid carcinoma-pregnancy” interaction among cancer survivors. Material and Methods: The clinical records of 8 pregnant women who received treatment for papillary thyroid cancer before...

Revaluating the survival effects of International Federation of Gynecology and Obstetrics 1988 stage IIIA criteria for endometrial cancer

Objective: This study aimed to define factors that affected survival in the International Federation of Gynecology and Obstetrics (FIGO) 1988 stage IIIA endometrial cancer (EC). Material and Methods: The study included...

Comparative surgical resection of the ligamentum teres hepatis in a cadaveric model and a patient with ovarian cancer

Resection of all tumor implants with the aim of maximal cytoreduction is the main predictor of overall survival in ovarian carcinoma. However, there are high risk sites of tumor recurrence, and the perihepatic region, es...

Download PDF file
  • EP ID EP551496
  • DOI 10.4274/jtgga.galenos.2018.2018.0039
  • Views 61
  • Downloads 0

How To Cite

Mehmet Yalçın Günal, Mehmet Ozansoy, Ülkan Kılıç, İlknur Keskin, Ekrem Musa Özdemir, İsmail Aslan, Zehra Eren, Cenk Ersavaş, Ertuğrul Kılıç (2019). Role of erythropoietin and its receptor in the development of endometriosis in rats. UNKNOWN, 20(1), 41-46. https://europub.co.uk/articles/-A-551496